MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Proceeds from maturitiesof investments$380,760K Return of related partyshort-swing profits$215K Net cash provided byinvesting activities$103,767K Net cash provided byfinancing activities$148K Canceled cashflow$276,993K Canceled cashflow$67K Net change in cash,cash equivalents and...-$86,099K Canceled cashflow$103,915K Stock-based compensation$37,059K Depreciation andamortization of property and...$8,871K Amortization of finance leaseright of use asset$2,154K Prepaid expenses andother assets-$2,089K Impairment of operatinglease right-of-use...$262K Operating leaseliabilities and right of use...$45K Finance lease liability$35K Purchases of investments$276,553K Purchases of property andequipment$440K Repurchase of restrictedstock units to satisfy...$67K Net cash used inoperating activities-$190,014K Canceled cashflow$50,515K Net loss-$223,123K Accounts payable andaccrued expenses-$10,351K Accretion of discount oninvestments, net$6,974K Other liabilities-$81K
Cash Flow
source: myfinsight.com

ROCKET PHARMACEUTICALS, INC. (RCKTW)

ROCKET PHARMACEUTICALS, INC. (RCKTW)